Enabling Precision Cancer Medicine In Sweden – A Collaborative Effort

15 oktober, 2019

About the day

Genomic Medicine Sweden is hosting a full-day symposium ”Enabling Precision Cancer Medicine in Sweden – A Collaborative Effort” on November 25 2019 at BioMedicum, Solna campus. The symposium is sponsored by Bayer, Bristol-Myers Squibb and Roche, and will focus on ongoing precision medicine efforts for cancer. The purpose is to highlight ongoing efforts for solid tumors and explore what the future might have in store. In addition our featured panel discussion will highlight the importance of the need for a collaborative effort between academia, healthcare and industry in order to envision and deliver precision health to healthcare on a broad scale.

Register here

If you are not able to attend, you can follow the symposium here:

Monday November 25

}

8:30am – 9:00am

BioMedicin-1

Coffee and Registration

 

}

9:00am – 10:00am

BioMedicum-1

Welcome and Introduction Talks

  • Professor Richard Rosenquist Brandell, Director, Genomic Medicine Sweden
  • Dr. Jenni Nordborg, Director, National Coordinator, Life Sciences at the Government Offices
  • Professor Hans Hägglund, National Cancer Coordinator,The Swedish Association of Authorities and Regions (SKL)
}

10:00am – 10:45am

BioMedicum-1

Keynote speaker

Dr. Ahmet Zehir, Director Clinical Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, USA

}

10:45am – 11:00am

BioMedicum-1

Coffee break

 

}

11:00am – 12:15pm

BioMedicum-1

Short talks in Precision Cancer Medicine, Solid Tumors

  • Dr. Anders Edsjö, co-chair Genomic Medicine Sweden Solid Tumors Working Commitee
  • Dr. Peter Asplund, Study Director The MEGALiT study, Uppsala University Hospital
  • Professor Alena Skálová, Bioptická laborator and Charles University, Faculty of Medicine, Pilsen, The Czech Republic
  • Dr. Gracy Crane, Senior Principal Scientist, Roche, Hertfordshire, United Kingdom
}

12:15pm – 1:15pm

BioMedicum-1

Lunch break

 

}

1:15pm – 2:00pm

BioMedicum-1

Panel discussion: Enabling Precision Cancer Medicine thru Collaboration

Moderator: Dr. Frida Lundmark, Programme Director, Vinnova

Panelists:

  • Gracy Crane, Roche
  • Aurora Seminara, BMS
  • Alena Skálová, Bioptická
  • Ahmet Zehir, MSKCC
  • Peter Asplund, Uppsala University Hospital
  • Margareta Haag, Nätverket mot Cancer
  • Johan Botling, GMS
}

2:00pm – 2:20pm

BioMedicum-1

Precision Cancer Medicine, a Multi-Omics Approach

Päivi Östling, Associate Professor, co-Principal Investigator at Olli Kallioniemi SciLifeLab Research group KI Dept. of Oncology and Pathology

}

2:20pm – 2:40pm

BioMedicum-1

Coffee break

 

}

2:40pm – 3:40pm

Parallel Sessions

A. Diagnostics of Fusion Genes, Inghesalen, Widerströmska huset, Tomtebodavägen 18, KI Solna Campus
Prof. Alena Skálová, Bioptická laborator, and Dr. Henrik Fagman, Sahlgrenska University Hospital

B. Liquid Biopsies, BioMedicum-1, BioMedicum
Dr. Aurora Seminara, Bristol-Myers Squibb, and Dr. Jonas Nilsson, Umeå University

C. Mutational Signatures, BioMedicum-2, BioMedicum
Assoc. Prof. Johan Staaf, Lund University, Assoc. Prof. Johan Botling, Uppsala University, Dr. Simon Ekman, Karolinska University Hospital

D. Clinicogenomic Database, J3:06 Ulf von Eulers, BioClinicum, Solna Vägen 30, KI Solna Campus
Dr. Gracy Crane, Roche, and Dr. Per Sikora, Gothenburg University

}

3:50pm – 4:00pm

BioMedicum-1

Summary & Wrap Up

Moderator: Richard Rosenquist Brandell, Director, Genomic Medicine Sweden
Parallel sessions panelist: Henrik Fagman (A), Jonas Nilsson (B), Johan Staff (C), and Per Sikora (D)

 

Organizing committee: Michael Akhras, Anders Edsjö, Richard Rosenquist Brandell, och Johan Botling

Symposium sponsors: